FDA Talks Transparency. Drug Cos. Ask How Far It Will Go
When the U.S. Food and Drug Administration recently published more than 200 rejection letters for new drug applications, agency officials called it "radical transparency."...To view the full article, register now.
Already a subscriber? Click here to view full article